These findings suggest different regulations of adiponectin and lipoproteins in MS than in a healthy state, which might be, at least in part, responsible for the lack or weakening of the associations between adiponectin and the lipoproteins in patients with MS. The gene discussed is ADIPOQ; the disease is myeloid sarcoma.